Investigation of Novel Small Molecular TRPM4 Inhibitors in Colorectal Cancer Cells

(1) Background: Transient receptor potential melastatin (TRPM4) ion channel aberrant expression or malfunction contributes to different types of cancer, including colorectal cancer (CRC). However, TRPM4 still needs to be validated as a potential target in anti-cancer therapy. Currently, the lack of...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Paulina Stokłosa, Anna Borgström, Barbara Hauert, Roland Baur, Christine Peinelt
Format: article
Langue:EN
Publié: MDPI AG 2021
Sujets:
Accès en ligne:https://doaj.org/article/c1e2856b9b9d4b049042d1da2ff96539
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!